Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.
Krassnig S, Leber SL, Orthmann A, Golob-Schwarzl N, Huber HJ, Wohlrab C, Skofler C, Pennauer M, Raicht A, Birkl-Toeglhofer AM, Naumann M, Mahdy-Ali K, von Campe G, Leoni M, Alcaniz J, Hoffmann J, Wälchli T, Weis S, Benesch M, Haybaeck J.
Krassnig S, et al. Among authors: orthmann a.
J Neurooncol. 2023 Oct;165(1):91-100. doi: 10.1007/s11060-023-04451-y. Epub 2023 Oct 31.
J Neurooncol. 2023.
PMID: 37907716
Free PMC article.